Biological monitoring for mutagenic effects of occupational exposure to butadiene.
The use of biological markers in the evaluation of human exposure to hazardous agents has increased rapidly in recent years. Because 1,3-butadiene is a mutagenic carcinogen, existing occupational levels of exposure may be appropriately evaluated using somatic cell mutation as a biomarker. Previously, we have described a biomarker study of workers in a butadiene monomer plant (Ward et al., 1994). We now report results from a second study of the same group of workers, conducted after plant modernization, and present preliminary results from a study of exposures in a styrene butadiene rubber (SBR) plant. Air levels of butadiene were determined using either charcoal tubes with air pumps or passive badge dosimeters. The quantity of a butadiene metabolite in the urine was used as a biomarker of exposure and the mutagenic effects of exposure were measured using the autoradiographic hprt mutant lymphocyte assay. In all three studies, the frequencies of hprt mutants were significantly elevated in workers from the areas of highest exposure when compared to workers from lower exposure areas or non-exposed subjects. The concentration of the urinary metabolite was significantly increased in high-exposed workers in the first study of monomer plant workers but not in the second. In the first monomer plant study, historical air concentrations of butadiene were higher in the production units than in the central control unit. While concurrent determined air concentrations were not elevated in the second monomer plant study, they were elevated in high exposure areas in the SBR plant study. Mutant frequencies in the lower-exposure and the non-exposed groups were consistent with historical values for non-smoking individuals who were not exposed to known mutagens. The use of biomarkers, including the hprt mutant lymphocyte assay, may be of great value in determining an appropriate occupational exposure limit for butadiene.
Ward
J B
JB
Department of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston 77555-1147, USA.
Ammenheuser
M M
MM
Whorton
E B
EB
Bechtold
W E
WE
Kelsey
K T
KT
Legator
M S
MS
D002070:Butadienes / Q000633:toxicity*; D004784:Environmental Monitoring; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase / Q000235:genetics; D009153:Mutagens / Q000633:toxicity*; D009154:Mutation; D016273:Occupational Exposure / Q000009:adverse effects*; D012408:Rubber; D012907:Smoking / Q000009:adverse effects; D020058:Styrene; D013343:Styrenes / Q000633:toxicity
D002070:Butadienes; D009153:Mutagens; D013343:Styrenes; D020058:Styrene; D012408:Rubber; D007041:Hypoxanthine Phosphoribosyltransferase; C031763:1,3-butadiene